LIMAA TECHNOLOGIES
Over 140+ Years of Combined Professional Expertise in the Medical Industry
Our interdisciplinary team brings together clinical excellence, deep research expertise, regulated software development, automation experience, and MedTech commercialization to shape the future of 3D histopathology.
✓ Diagnostic Excellence ✓ Regulated IVD Development ✓ Assay, Hardware & MedTech Expertise
Our missionWe set the foundation for precision medicine.
Regulated software, proprietary reagents, and hardware used in medical applications
Built by clinicians, researchers, engineers, and MedTech operators
Collaborative development focused on clinical impact and adoption
The Foundation of Our Success
LIMAA is built by a team that covers the full journey from scientific invention to clinical validation, regulated productization, production, commercialization, and brand building. This combination is especially important because 3D histopathology must be scientifically robust, clinically relevant, technically reliable, and scalable in regulated healthcare environments.
Meet the Minds Behind LIMAA
17+ YEARS
OF EXPERTISE
Managing Director | Head of
Business Development | CO-FOUNDER
DR. FABIAN MOHR
Combines cancer research, software development, strategic consulting, venture capital, and life-science company building experience.
Transforms LIMAA's scientific innovation into strategy, partnerships, financing logic, market positioning, and long-term business development.
Managing Director | Head of Operations & IT | CO-FOUNDER
MÉLANIE GUENTER
Brings more than two decades of experience at the interface of regulatory and quality management, finance, software development, operations and process excellence.
Builds the structures, processes and leadership discipline needed to turn complexity into scalable execution and operational reliability.
Head of MA & SA | Head of Pathology |
CO-FOUNDER
CAMILA TOMIKAWA, MD
Pathologist with medical informatics expertise and experience advising digital pathology startups on AI model development, validation, and clinical decision-support systems.
Connects LIMAA's technology to real laboratory workflows, clinical validation requirements, and pathologist-centered usability.
30+ YEARS
OF EXPERTISE
ppa. | Head of Research |
CO-FOUNDER
DR. DR. RENÉ HÄGERLING
Chemist and board‑certified human geneticist with deep expertise in 3D histology, light‑sheet microscopy, nanobody‑based staining and translational tissue analysis.
Provides the scientific and technological core of LIMAA: non-destructive 3D histopathology, spatial tissue analysis, and clinical translation.
DR. GEORG KOX
Head of Marketing & Sales
Healthcare entrepreneur with experience in venture building, marketing, sales, and growth strategies for medical companies.
Builds market access, positioning, sales strategy, and stakeholder communication.
Biologist with over 12 years of practical experience in IVD development and regulated product
design and lifecycle environments.
Enriches LIMAA with deep IVD development knowledge, leading the team through product development in regulated environments.
Head of Development
VANESSA KUHL
NADINE HÜLSEMANN
Head of Production
Biologist with more than 12 years of experience in the in vitro diagnostics production and laboratory process setup.
Industrializes the platform through repeatable production, process optimization, automation, and stable workflows.
25+ YEARS
OF EXPERTISE
DR. JENNIFER DOEDT
Head of RA & QA
Biologist with more than 15 years of experience in the in vitro diagnostics sector, including 4 years with a Notified Body.
Strengthens LIMAA with regulatory, QA, and compliance expertise in highly regulated environments.
15+ YEARS
OF EXPERTISE
17+ YEARS
OF EXPERTISE
12+ YEARS
OF EXPERTISE
15+ YEARS
OF EXPERTISE
12+ YEARS
OF EXPERTISE
Interdisciplinary Synergy
Get in touch to learn more about LIMAA and discover how our integrated approach supports the future of digital histopathology.
Whether you’re interested in career opportunities or a product demo, we’d love to hear from you.